The 4 analysts offering 12-month price forecasts for Immunic Inc have a median target of 10.00, with a high estimate of 39.00 and a low estimate of 5.00. The median estimate represents a +281.68% increase from the last price of 2.62.
The current consensus among 4 polled investment analysts is to Buy stock in Immunic Inc. This rating has held steady since January, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.73
Reporting Date Feb 24
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.